Clinical Trial Update: Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 Years [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating repeated Bacillus Calmette-Guérin (BCG) vaccinations as a treatment for new-onset Type 1 diabetes in children aged 8 to unde…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• BCG vaccine (Bacillus Calmette-Guérin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Diabetes Mellitus, Type 1 Diabetes | Phase 2 | Status: RECRUITING